Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > The great conspiracy of 2021
View:
Post by 1ottrunner on May 08, 2021 7:02am

The great conspiracy of 2021

If you've come to this message board looking for a bit of DD and some intelligent conversation, leave now.

There is no conspiracy.

RVV currently has 27 sites.  The trial offers $XXX.XX to be a participant and follow protocol.

You present with mild to moderate symptoms and you are offered the money to complete the course of treatment.

How many participants will complete the course of treatment?  90% maybe, more less...depends on the money they are offering.

Now lets say Bob decides to flush his Bucillamine rather than swallow it.  How is that qualified?

There are a lot of issues with an outpatient trial like this.  Even if Bucillamine is 100% effective it could fail due to participant error.

Is the participant going to the clinic every day for the course of treatment for observation?

The FDA and Pfizer have better things to do than get involved in this tiny trial.

Good luck guys, time to give up this handle to the next idiot and move on to another.
Comment by TheTerminator1 on May 08, 2021 7:25am
Will you stop with the negative talk...
Comment by 1ottrunner on May 08, 2021 8:36am
Yep, as soon as the morons stop talking about the Conspiracy between the FDA and Pfizer to keep RVV down. Fair? I'm an investor. You find my posts negative?  Why?  Because I won't say there is a 100% chance the Buc trial will be successful?  110%  would that be enough? How about this, I think there is a 25% chance the trial will offer data sufficient to get EUA ...more  
Comment by TheTerminator1 on May 08, 2021 8:51am
You said it and i agree 100% It's the frigin FDA and Pfizer shorting the stock! They will eventually need our help because there is no way in the world they will be able to contain this virus without Therapeutics like Bucillamine and many others.
Comment by 1ottrunner on May 08, 2021 9:02am
I said it mocking, you believe it! You want to contain this virus, get vaccinated! In 60 days about 70% of the population in this hemisphere will be vaccinated and we will proceed with business as usual.   Mild cases of Covid will still occur so there may still be a place for therapies like Buccilamine if they can pass the muster of the FDA (not involved in a conspiracy).
Comment by TheTerminator1 on May 08, 2021 9:12am
First of all,i had my 1st dose and i am looking forward to the 2nd and 3rd doses...I do not want to become a Long-Hauler like several pople i know. They need to vaccinate the World not just OUR HEMISPHERE...WE do not live in a bubble and they will not comdemn or keep the people from traveling accross the world... Expect another wave THIS FALL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities